 Biotricity Inc OTC: BTCY has a multi-billion dollar target addressable market, which should expand as an ecosystem is created for solutions to chronic conditions, according to Maxim Group. The Biotricity Analyst: Allen Klee initiated coverage of Biotricity with a Buy rating and a price target of 6. 